These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17676310)

  • 21. Identification of a proglucagon cDNA from Rana tigrina rugulosa that encodes two GLP-1s and that is alternatively spliced in a tissue-specific manner.
    Yeung CM; Chow BK
    Gen Comp Endocrinol; 2001 Nov; 124(2):144-51. PubMed ID: 11703080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like peptide 2 function in domestic animals.
    Burrin DG; Stoll B; Guan X
    Domest Anim Endocrinol; 2003 Mar; 24(2):103-22. PubMed ID: 12586312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effect of glucagon-like peptide 2 (GLP-2) and of key growth factors on the proliferation of cultured rat astrocytes. Evidence for reciprocal upregulation of the mRNAs for GLP-2 and IGF-I receptors.
    Velázquez E; Blázquez E; Ruiz-Albusac JM
    Mol Neurobiol; 2009 Oct; 40(2):183-93. PubMed ID: 19672727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans.
    Meier JJ; Nauck MA; Pott A; Heinze K; Goetze O; Bulut K; Schmidt WE; Gallwitz B; Holst JJ
    Gastroenterology; 2006 Jan; 130(1):44-54. PubMed ID: 16401467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration.
    El-Jamal N; Erdual E; Neunlist M; Koriche D; Dubuquoy C; Maggiotto F; Chevalier J; Berrebi D; Dubuquoy L; Boulanger E; Cortot A; Desreumaux P
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G274-85. PubMed ID: 24875097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.
    Bucinskaite V; Tolessa T; Pedersen J; Rydqvist B; Zerihun L; Holst JJ; Hellström PM
    Neurogastroenterol Motil; 2009 Sep; 21(9):978-e78. PubMed ID: 19453518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of proglucagon and proglucagon-derived peptide hormone receptor genes in the chicken.
    Richards MP; McMurtry JP
    Gen Comp Endocrinol; 2008 Apr; 156(2):323-38. PubMed ID: 18299131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets.
    Kieffer TJ; Heller RS; Unson CG; Weir GC; Habener JF
    Endocrinology; 1996 Nov; 137(11):5119-25. PubMed ID: 8895386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse.
    Campos RV; Lee YC; Drucker DJ
    Endocrinology; 1994 May; 134(5):2156-64. PubMed ID: 8156917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.
    Hansen L; Hartmann B; Bisgaard T; Mineo H; Jørgensen PN; Holst JJ
    Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1010-8. PubMed ID: 10827002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals.
    Irwin DM
    Front Endocrinol (Lausanne); 2021; 12():700066. PubMed ID: 34322093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species-specific differences in agonistic activity of ago-allosteric modulators toward glucagon-like peptide 2 receptor.
    Yamazaki K; Takase K; Watanabe M; Kagaya T; Terauchi H; Iida D; Fukumoto H; Suzuki S; Arai T; Aoki M; Seiki T; Tsukahara K; Nagakawa J
    Biomed Res; 2012 Dec; 33(6):337-44. PubMed ID: 23268957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice.
    Ørgaard A; Holst JJ
    Diabetologia; 2017 Sep; 60(9):1731-1739. PubMed ID: 28551699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
    Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
    Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells.
    Lovshin JA; Huang Q; Seaberg R; Brubaker PL; Drucker DJ
    Endocrinology; 2004 Jul; 145(7):3495-506. PubMed ID: 15059959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspartame supplementation in starter accelerates small intestinal epithelial cell cycle and stimulates secretion of glucagon-like peptide-2 in pre-weaned lambs.
    Sun D; Liu L; Mao S; Zhu W; Liu J
    J Anim Physiol Anim Nutr (Berl); 2019 Sep; 103(5):1338-1350. PubMed ID: 31342562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
    Schirra J; Sturm K; Leicht P; Arnold R; Göke B; Katschinski M
    J Clin Invest; 1998 Apr; 101(7):1421-30. PubMed ID: 9525985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
    Banasch M; Bulut K; Hagemann D; Schrader H; Holst JJ; Schmidt WE; Meier JJ
    Regul Pept; 2006 Dec; 137(3):173-8. PubMed ID: 16928403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.